Staar Surgical Announces Leadership Overhaul After Failed Alcon Merger and Shareholder Deal
Staar Surgical announced significant leadership changes following a settlement with Broadwood Partners. The move follows a failed merger with Alcon Inc.
洞察:
stephen farrell, the chief executive officer of the US
USbased Staar Surgical Company , will step down from his position by the end of January 2026. This announcement comes as part of a formal settlement agreement with Broadwood Partners, the company's largest shareholder which currently holds a 31.07% stake. In addition to the upcoming departure of stephen farrell, Board Chair elizabeth yeu has already stepped down from her role on the board as part of the leadership transition.
The governance changes follow the recent termination of a merger agreement with Alcon Inc . The Switzerland
CHbased Alcon Inchad initially offered $1.5 billion to acquire the business, later increasing its final offer to $1.6 billion last month. However, Broadwood Partners actively opposed the acquisition, stating that the offers undervalued the Staar Surgical Companyand reflected a flawed sale process. The merger agreement was officially terminated earlier in January 2026 after the company failed to secure sufficient shareholder votes to approve the deal.











